Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records β€” linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review claims


     Quick Explanation



    Author snapshot β€” Even Fossum

    Even Fossum is a productive immunology/virology co-author on multiple high-impact papers (examples below) and is listed in OpenAlex with ~58 works, ~3,062 citations and h-index β‰ˆ25 (OpenAlex aggregate) β€” his publication record includes highly-cited papers in PLoS Pathogens, Science and Immunity showing work on herpesviral interactomes and dendritic cell biology.

    • Herpesviral interactome (first-author): Fossum is first author on a widely-cited conserved herpesviral interaction network (PLoS Pathogens 2009)
    • Dendritic cell / XCR1 work: Fossum is co-author on several influential dendritic-cell papers in Immunity and Journal of Immunology mapping DC subsets and XCR1 expression (Immunity 2016; J Immunol 2011)

    For a rigorous author-level metric breakdown and per-year publication/citation visualization, run the BGPT AI Scientist agent (one-click) to fetch raw OpenAlex records, per-paper citations, and to graph counts-by-year.




     Long Explanation



    Author Review β€” Even Fossum

    Quick visual summary (visualize first, read second)

    Graphs below show (A) selected high-impact papers where Fossum is author/co-author and (B) a per-paper citation bar to illustrate relative influence among representative works (raw citation counts from publishers / indexing services cited inline beneath the figure).

    Graph data source notes: citation counts are taken from publisher/Indexing records for the cited DOIs below; they illustrate that Fossum has co-authored multiple widely-cited, resource-style papers (systems and immunology), consistent with an author with significant impact in viral–host interactomics and dendritic cell biology.


    Evidence-based strengths (what the record shows)

    • High-impact collaborative work: Fossum is co-author on multi-author, highly-cited papers mapping viral protein interactions and dendritic-cell phenotypes β€” e.g., PLoS Pathogens 2009 (conserved herpesviral interactome) and Immunity 2016 (dendritic cell alignment) which are resource-like studies used widely by other groups
    • Breadth across immunology and virology: Top-works list indicates contributions spanning interactomics, interferon antagonism, and dendritic cell targeting; this interdisciplinary footprint increases the likelihood that the author contributed experimental and/or analytic skills across labs

    Evidence-based weaknesses, blindspots, and limitations

    • Authorship position mix: Many highly-cited works list Fossum in middle-author positions on large collaborative studies; middle authorship is common in resource papers but makes attribution of intellectual leadership uncertain unless corresponding/first-author roles are shown in specific papers (some first-author papers exist, e.g., PLoS Pathogens 2009 listed earlier where Fossum is first author)
    • Methodological constraints in cited papers: Several influential papers use yeast two-hybrid or large-scale cytometry; these methods are powerful for discovery but have known biases (Y2H under-detects transient/complex interactions; cytometry depends on marker panels and gating/computational alignment can introduce batch-driven artefacts)
    • Heterogeneous institutional affiliations in records: Open metadata shows variable last-known institutions; lack of a clear, consistent primary institution in some aggregations can make assessing lab environment, funding, and resource access harder (this matters for reproducibility and scale of experiments). (OpenAlex metadata summarized below in the per-year counts visualization.)

    Interpretation and balanced judgement

    Taken together, the bibliographic evidence indicates Even Fossum is an experienced researcher active at the intersection of virology and immunology with participation in multiple high-impact, resource-style collaborative studies (some where he is first author and others where he is a contributing co-author). The strongest signals of scientific strength are the high citation counts of several co-authored resource papers, which suggests his work has produced reusable datasets or tools used broadly across the field

    What would change this judgement (data that would overturn current conclusion)

    • Discovery of a consistent pattern of irreproducible results or retractions across Fossum-led papers would significantly lower confidence.
    • Clear documentation of leadership (corresponding author, PI) on additional high-quality, independently-validated experimental papers would raise the scientific score.
    • Detailed institutional, funding, and protocol-level metadata showing reproducible methods and open raw data would strengthen inferences about rigor and impact.

    Actionable next steps (run BGPT agent to fetch raw records)

    I can fetch the full OpenAlex raw author record (per-paper DOIs, per-paper citation trajectory, authorship positions, open-access PDFs where available) and produce per-year plots of works_count and cited_by_count, plus an authorship-role breakdown pie chart. This requires running the BGPT AI Scientist agent to query OpenAlex / publisher APIs and fetch raw data.

    (Agent will produce: complete OpenAlex author export, per-paper citation timelines, authorship-role parsing, and reproducibility indicators such as availability of raw data / methods.)


    Representative source citations used in this review

    If you want the full raw-author export (per-paper DOIs, exact authorship positions, per-paper OA links, per-year counts and interactive plots), click the agent button above and I'll run the BGPT AI Scientist agent to deliver a complete reproducibility-oriented dossier.



    Feedback:    

    Updated: March 16, 2026

     BGPT Author Review



    Scientific Quality

    70%

    Fossum's record shows clear contributions to several highly-cited, resource-style papers in virology and immunology (strong evidence of impact and technical competence). Strengths: participation in resource datasets and immunology/virology interdisciplinary work; presence as first author on at least one major resource paper. Limits: many high-impact items are collaborative/multi-author so leadership attribution varies; method-specific biases (e.g., Y2H) in major works require orthogonal validation; institution metadata is heterogeneous, making assessment of sustained PI-level leadership less certain.



    Communication Quality

    70%

    Papers linked to Fossum are published in clear, widely-read journals (Science, Immunity, PLoS Pathogens) with reproducible-data emphasis and public datasets; that indicates above-average academic communication and data sharing practices, but a mixed pattern of first/last authorship leaves some uncertainty about solo clarity of messaging.



    Author Novelty

    60%

    Work sits at the intersection of systems virology and dendritic cell immunology β€” combining large-scale interactomics and high-dimensional cell phenotyping is not entirely novel in 2026 but Fossum contributed to influential resource papers that advanced methods and cross-species alignment; novelty is solid but not paradigm-shifting.



    Scientific Rigor

    60%

    Rigor is moderate-to-high: publications appear in rigorous, peer-reviewed high-quality journals and often include large datasets; however, major methodological approaches (Y2H, high-dimensional cytometry) have known limitations and require orthogonal validation β€” the presence or absence of such validation across all Fossum-led projects determines final rigor.

     Analysis Wizard



    Retrieving OpenAlex author record, parsing per-work DOIs/authorship positions, and producing per-year citation/time series for visualization.



     Hypothesis Graveyard



    Hypothesis: Fossum has led independent translational clinical trials β€” rejected because available records show predominantly basic-resource and preclinical immunology/virology studies rather than clinical-trial leadership.


    Hypothesis: All high-citation papers list Fossum as corresponding author β€” rejected because authorship positions are mixed and many resource papers list other PIs/corresponding authors.

     Science Art


    Author Review: Even Fossum Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT